EDIT vs SO
Editas Medicine Inc (EDIT) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported SO revenue for 2016-09-30 was $6.26B. Net income was $1.17B. Revenue was down 25.9% from 2016-06-30 to 2016-09-30. SO currently screens at market cap $101.55B and trailing P/E 22.1.
EDIT currently screens at market cap $375.2M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the EDIT and SO stock pages for the full models.
Not investment advice.